TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number June 17, 2011
TCL Archive Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator” April 5, 1985
TCL Archive Brown Disagrees With Staff, Subgroup On Dichlorvos, Says It Is a Carcinogen September 2, 1977